lipid lowering treatment
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
... and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, two-component clinical trial sponsored by the National Heart, Lung, and Blood Institute ...to treatment ...
9
Adherence to lipid-lowering treatment: the patient perspective
... effective lipid-lowering medications, such as the HMG-CoA reductase inhibitors (statins), a large portion of the population has low- density lipoprotein cholesterol (LDL-C) levels greater than the ...
10
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
... in lipid-lowering treatment goal attainment rate with large-scale nationwide ...C treatment goal attainment such as the level of physical activity, psychological factors, family income, and ...
8
Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
... on treatment (group 3) as well as individuals with LDL ≥ 130 mg/dL (groups 4 and 5) displayed greater carotid atherosclerotic disease burden, as compared with untreated individuals with usual LDL <100 mg/ dL ...
10
Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics
... In recent years, visit-to-visit variability of serum lipids has been linked to both clinical outcomes and surrogate markers for vascular disease. In this article, we present an overview of the current evidence connecting ...
27
Early Effects of Intensive Lipid Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound
... intensive lipid-lower- ing treatment (ezetimibe/simvastatin 10/40 mg) on plaque characteristics in ACS patients compared with the effects of control statin treatment (pravastatin 20 mg) ...of ...
8
Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment
... of lipid or glucose metabolism and had glucose concentrations < 5,6 mmo/L, LDL-c concen- trations < 4,14 mmol/L and triglyceride concentra- tions < 2,25 ...after treatment for their dyslipidemia ...
6
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
... the lipid target (66% of patients with LDL-C measured at baseline and with an appropriate drug treatment) with a mean age of ...the lipid target appeared to be comparable with however a slightly ...
7
Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects
... recommended treatment targets for very high risk patients ...simvastatin treatment resulted in higher percentages of diabetic patients achieving not only the aggressive LDL-C target of <70 mg/dL, but ...
10
Uncontrolled hyperlipidemia in Chinese patients who experienced acute coronary syndrome: an observational study
... On the contrary, although intensive statin therapy was recommended in the inclusion criteria and all investigators were encouraged to follow study protocol, 25% of patients were not administered intensive statin therapy. ...
10
EuropePMC-PMC5392175.pdf
... fasting lipid parameters or commencement of lipid lowering treatment without a grade 2 or higher lipid ...higher lipid elevations by the DAIDS grading table translate to moderate ...
15
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
... received lipid-lowering treatment for > 3 months in order to investigate blood pressure (BP) as well as low-density lipoprotein cholesterol (LDL-C) goal attainment rates in Chinese hypertensive ...
11
Cardio classics revisited: focus on the role of amlodipine
... TOMHS, Treatment of Mild Hypertension Study; ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; PREVENT, Prospective Randomized Evaluation of the Vascular ...
7
Hypercholesterolemia effectively managed with homeopathic medicine Gautteria gaumeri (Yumel): results from a clinical study in academic clinical set up in north India
... Height (cm) Mean (SD) 157.07±26.18 Weight (Kg) Mean (SD) 71.5±11.78 BMI (Kg/sq meter) Mean (SD) 28.14±3.55 Systolic BP (mm Hg) Mean (SD) 133.09±7.47 Diastolic BP (mm Hg) Mean (SD) 81.62±2.66 Most of the population had ...
6
Emerging Nephrotic Problems among Diabetic Patients of Bangladesh
... and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT); Angiotensin-converting enzyme Inhibitors (ACE- Inhibitors); Angiotensin Receptor Blockers (ARBs); Bangladesh Institute of Research ...
7
The Impact of Statin Intolerance in Lipid Clinic Patients
... their lipid-lowering therapy, it is essential to reduce their cardiovascular ...another lipid modifying medications among high-risk patients who are intolerant or unresponsive to high intensity ...
8
Statins: Newer Roles Including Lipid Lowering Therapy
... addition, lipid- lowering therapy was associated with significant reduction in both cardiac mortality and all-cause death in larger cohort of patients treated with antiarrhythmic drug ...
10
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES
... post-infection lipid levels, those with acute HCV showed a significant reduction in TC and LDL levels compared to ...or treatment-induced viral clearance had a rebound in LDL and TC to levels at or above ...
9
Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease
... antioxidant capacity in CAD patients [26]. In addition, the level of LC was significantly positively correlated with antioxidant enzymes activity (SOD, β = 0.72, P < 0.01) and reduced oxidative stress and inflammatory ...
8
The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects
... improved lipid ratios (TC/HDL and LDL/HDL) either independent of placebo or relative to ...improved lipid ratios are due to reduced LDL, total cholesterol and increased HDL levels during the ...
10